Equivalence of SYN008 versus omalizumab in patients with refractory chronic spontaneous urticaria: A multicenter, randomized, double-blind, parallel-group, active-controlled phase III study

Equivalence of SYN008 versus omalizumab in patients with refractory chronic spontaneous urticaria: A multicenter, randomized, double-blind, parallel-group, active-controlled phase III study

Saved in:
Bibliographic Details
Main Authors: Jingyi Li, Yunsheng Liang, Wenli Feng, Liehua Deng, Hong Fang, Chao Ji, Youkun Lin, Furen Zhang, Rushan Xia, Chunlei Zhang, Shuping Guo, Mao Lin, Yanling Li, Shoumin Zhang, Xiaojing Kang, Liuqing Chen, Zhiqiang Song, Xu Yao, Chengxin Li, Xiuping Han, Guoxiang Guo, Qing Guo, Xinsuo Duan, Jie Li, Juan Su, Shanshan Li, Qing Sun, Juan Tao, Yangfeng Ding, Danqi Deng, Fuqiu Li, Haiyun Suo, Shunquan Wu, Jingbo Qiu, Hongmei Luo, Linfeng Li, Ruoyu Li, Lishao Guo
Format: Article
Language:English
Published: Wolters Kluwer 2025-08-01
Series:Chinese Medical Journal
Online Access:http://journals.lww.com/10.1097/CM9.0000000000003593
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://journals.lww.com/10.1097/CM9.0000000000003593

Similar Items